Therapeutic Health Focus Areas
Diverse Health Hub collects relevant and meaningful content for five therapeutic areas. Our focus allows us to organize and deliver health equity information regarding what is most important to you as a patient, patient care team member, or a healthcare provider.
Multiple myeloma is a blood disorder that begins in the plasma cells. Studies have shown that minority populations are at an elevated risk for myeloma, yet are under-represented in research.
Sickle cell disease is a blood disorder caused by mutation, and it affects millions of people. Sickle cell is more common among people of certain ancestries, including those of African, Caribbean, Middle Eastern, Eastern Mediterranean, and Asian descent.
Renal medullary carcinoma (RMC) is a very rare, aggressive, difficult-to-treat kidney cancer that predominantly impacts young people of African descent carrying the sickle cell trait or sickle cell disease.
Breast cancer survival and screening rates have improved significantly. However, incidence rates are higher among women of color and more often than not, these women are diagnosed at a later stage.
Clinical trials are responsible for numerous advancements in medicine and cures for a multitude of diseases. Evidence has shown that Hispanics, Asians and African-Americans are not adequately represented in clinical trials in the US.